EGRP staff nominated and voted for manuscripts published in 2015 by EGRP grantees that were deemed to have the greatest potential scientific and/or public health impact. Our paper titled Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response describing the use of whole exome sequencing for advanced cancer patients has been selected among the top 10. The full list of EGRP's 2015 Research Highlights can be found here.
Latest news from The Englander Institute for Precision Medicine:
Researchers in New York are now using virtual reality to delve deep inside the human body in hopes of unlocking a cure for cancer.
Researchers at Weill Cornell Medicine developed the genome sequencing software application.
Scientists say we're in a medical renaissance of sorts where the goal of curing cancer - the many different versions of it - may actually be in reach. NY1's Erin Billups has more in part two of her look at precision medicine.
In his State of the Union address President Barack Obama made finding a cure for cancer a moonshot of his final year in office. It's a lofty goal as cancer is not just one disease but many. But with the help of doctors at a New York institute one woman may have found her cure, tailored just for her. NY1's Erin Billups filed the following report.
PRECISION MEDICINE TEAM AT WEILL CORNELL MEDICINE AND NEWYORK-PRESBYTERIAN WILL INTRODUCE WHOLE EXOME SEQUENCING TEST, EXACT-1, TO CLINICAL SETTING
NEW YORK (November 13, 2015) — A powerful new test that can reveal untapped therapies for patients with advanced cancers by scanning thousands of their genes will soon be available for patients at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.